Acute interstitial nephritis after COVID-19 vaccination. Issue 5 (19th May 2022)

• Record Type: Journal Article
• Authors: Tan, Felicia SC; Kabir, Mohammad E; Bhandari, Sunil
• Is Part Of: BMJ case reports. Volume 15:Issue 5(2022)
• Publication Date: 2022-05-19
• Subjects: COVID-19 -- Immunological products and vaccines -- Unwanted effects / adverse reactions -- Acute renal failure -- Renal medicine; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2021-246841
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : A woman in her 70s presented to the hospital being generally unwell 8 days following the first dose of the AstraZeneca COVID-19 vaccination. She was in stage III acute kidney injury (AKI) with hyperkalaemia and metabolic acidosis. Urinalysis showed haematoproteinuria. Renal immunology screen was negative. She subsequently underwent two renal biopsies. The second biopsy showed features consistent with acute tubulointerstitial nephritis. She was commenced on oral steroids, which led to marked improvement of her renal function. There are reasons why AKI can occur post vaccination such as prerenal AKI from reduced oral intake postvaccination due to feeling unwell or developing vomiting or diarrhoea. Intravenous fluids were given to this patient but with no meaningful improvement in renal function. She developed a possible reaction to the AstraZeneca COVID-19 vaccine, which led to AKI as supported by the interstitial inflammation and presence of eosinophils on renal biopsy.